POSTED BY ISABEL TEARE | 27 JUNE 2021 Data protection adequacy decisions - just in time The EU has adopted final versions of the two adequacy decisions that were issued in draft earlier this year. These permit personal data flows to the UK under the GDPR and the Law Enforcement Directive. Read more Share this article Bookmark this page 1 min read Brexit Clinical trials Confidential information Employment Medical devices/Medtech Personalised medicine
POSTED BY ISABEL TEARE | 6 JUNE 2021 Plans for a multilateral pharmaceutical merger task force The aim is to identify concrete and actionable steps to review and update the analysis of pharmaceutical mergers, and address perceived harms around price increases and anti-competitive conduct. Share this article Bookmark this page 2 min read
POSTED BY ISABEL TEARE | 6 JUNE 2021 The 2021 ABPI Code takes effect soon The UK pharma sector is readying itself for the introduction of the new ABPI Code, bringing in extensive changes to the industry's self-regulatory system. Share this article Bookmark this page 1 min read
POSTED BY ISABEL TEARE | 24 MAY 2021 EU Parliament calls for review of UK's data privacy regime The European Parliament has asked the EU Commission to take another look at the UK's data protection adequacy assessment. Share this article Bookmark this page 1 min read
POSTED BY ISABEL TEARE | 18 MAY 2021 Issues to consider when exploiting commercial opportunities in People’s Republic of China As the Chinese life sciences market continues to grow and develop, the Chinese government continues to de-regulate or streamline its regulatory pathways (such as its drug approval regimes). And as Chinese parties seek to exploit foreign technologies... Share this article Bookmark this page 4 min read
POSTED BY ISABEL TEARE | 22 APRIL 2021 EU bid to control the future of AI This week saw the publication of long-expected draft EU legislation aimed at regulating artificial intelligence systems of all kinds. These broad proposals indicate a willingness to take an... Share this article Bookmark this page 1 min read
POSTED BY ISABEL TEARE | 22 APRIL 2021 UK considers reform to GMO regulations As explained in DEFRA’s supporting documents, GMOs generally involve the introduction of genetic material into an organism. The classic example is lifting DNA from one species and inserting into a... Share this article Bookmark this page 3 min read
POSTED BY ISABEL TEARE | 10 MARCH 2021 Next steps for life sciences regulation in the UK As the UK's Medicines and Medical Devices Act 2021 becomes law, we review what... Share this article Bookmark this page 1 min read
POSTED BY ISABEL TEARE | 22 FEBRUARY 2021 Good news for EEA/UK personal data flows The EU Commission has now published draft adequacy decisions for transfers of personal data to the United Kingdom, under both the GDPR and the Law Enforcement Directive. This is welcome news, as it will provide a greater degree of certainty... Share this article Bookmark this page 2 min read
POSTED BY ISABEL TEARE | 6 JANUARY 2021 The EU-UK Trade and Cooperation Agreement - life sciences December's announcement of a Trade and Cooperation Agreement to steer the next steps in the future relationship between the UK and the EU was a welcome development. Share this article Bookmark this page 1 min read
Subscribe Receive blog alerts via email from our leading team of legal experts Register Visitor Login